BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27327081)

  • 1. Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge.
    Zhao S; Mei Y; Wang J; Zhang K; Ma R
    PLoS One; 2016; 11(6):e0157639. PubMed ID: 27327081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
    Wang XF; Wu YH; Wang MS; Wang YS
    Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical significance of CA125, CA153 and CEA in nipple discharge of breast cancer patients.
    Geng J; Jinli S; Guo W; Li H; Dan Y; Gao Y
    J Med Biochem; 2024 Apr; 43(2):234-242. PubMed ID: 38699697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.
    Wang G; Qin Y; Zhang J; Zhao J; Liang Y; Zhang Z; Qin M; Sun Y
    Int J Mol Sci; 2014 May; 15(6):9546-65. PubMed ID: 24879526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Values of Carcinoembryonic Antigen, Cancer Antigen 15-3 and Cancer Antigen 125 Levels in Nipple Discharge.
    Zhao S; Gai X; Wang Y; Liang W; Gao H; Zhang K; Wang H; Liu Y; Wang J; Ma R
    Chin J Physiol; 2015 Dec; 58(6):385-92. PubMed ID: 26717917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
    Zhu FL; Ling AS; Wei Q; Ma J; Lu G
    Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High-Risk Populations.
    Li G; Zhang H; Zhang L; Liu H; Li S; Wang Y; Deng X
    Biomed Res Int; 2022; 2022():1394042. PubMed ID: 36299704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.
    Zhang SJ; Hu Y; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
    Asian Pac J Cancer Prev; 2013; 14(6):3937-40. PubMed ID: 23886210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of CEA, CA153, CA199, CA724 and AFP in nipple discharge of breast cancer patients.
    Zhao S; Mei Y; Wang Y; Zhu J; Zheng G; Ma R
    Int J Clin Exp Med; 2015; 8(11):20837-44. PubMed ID: 26885008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of five preoperative serum tumor markers and pathological features in patients with breast cancer.
    Lian M; Zhang C; Zhang D; Chen P; Yang H; Yang Y; Chen S; Hong G
    J Clin Lab Anal; 2019 Jun; 33(5):e22875. PubMed ID: 30843272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer.
    Shan D; Cheng S; Ma Y; Peng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1039-1049. PubMed ID: 37724407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
    Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
    Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.
    Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen estimation in nipple discharge as an adjunctive tool in the diagnosis of early breast cancer.
    Inaji H; Yayoi E; Maeura Y; Matsuura N; Tominaga S; Koyama H; Takatsuka Y; Mori T
    Cancer; 1987 Dec; 60(12):3008-13. PubMed ID: 3677024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
    Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
    Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of determination of CEA, CA125, CA153 and CA199 assay in pleural fluid for lung cancer].
    Wu G; Ba J; Wang E; Teng Y; Fan X
    Zhongguo Fei Ai Za Zhi; 2004 Feb; 7(1):35-7. PubMed ID: 21211189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
    Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
    Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for five tumour markers in the screening and diagnosis of female breast cancer.
    Luo J; Xiao J; Yang Y; Chen G; Hu D; Zeng J
    Front Oncol; 2022; 12():1055855. PubMed ID: 36755860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
    Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
    Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.